Literature DB >> 26311892

Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.

Anna L McNaughton1, Iain Dugald Cameron1, Elizabeth B Wignall-Fleming1, Roman Biek2, John McLauchlan1, Rory N Gunson3, Kate Templeton4, Harriet Mei-Lin Tan1, E Carol McWilliam Leitch5.   

Abstract

UNLABELLED: A more comprehensive understanding of hepatitis C virus (HCV) transmission dynamics could facilitate public health initiatives to reduce the prevalence of HCV in people who inject drugs. We aimed to determine how HCV sequences entered and spread throughout Scotland and to identify transmission hot spots. A Scottish data set with embedded demographic data was created by sequencing the NS5B of 125 genotype 1a (Gt1a) samples and 166 Gt3a samples and analyzed alongside sequences from public databases. Applying Bayesian inference methods, we reconstructed the global origin and local spatiotemporal dissemination of HCV in Scotland. Scottish sequences mainly formed discrete clusters interspersed between sequences from the rest of the world; the most recent common ancestors of these clusters dated to 1942 to 1952 (Gt1a) and 1926 to 1942 (Gt3a), coincident with global diversification and distribution. Extant Scottish sequences originated in Edinburgh (Gt1a) and Glasgow (Gt3a) in the 1970s, but both genotypes spread from Glasgow to other regions. The dominant Gt1a strain differed between Edinburgh (cluster 2 [C2]), Glasgow (C3), and Aberdeen (C4), whereas significant Gt3a strain specificity occurred only in Aberdeen. Specific clusters initially formed separate transmission zones in Glasgow that subsequently overlapped, occasioning city-wide cocirculation. Transmission hot spots were detected with 45% of samples from patients residing in just 9 of Glasgow's 57 postcode districts. HCV was introduced into Scotland in the 1940s, concomitant with its worldwide dispersal likely arising from global-scale historical events. Cluster-specific transmission hubs were identified in Glasgow, the key Scottish city implicated in HCV dissemination. This fine-scale spatiotemporal reconstruction improves understanding of HCV transmission dynamics in Scotland. IMPORTANCE: HCV is a major health burden and the leading cause of hepatocellular carcinoma. Public health needle exchange and "treatment as prevention" strategies targeting HCV are designed to reduce prevalence of the virus in people who inject drugs (PWID), potentially mitigating the future burden of HCV-associated liver disease. Understanding HCV transmission dynamics could increase the effectiveness of such public health initiatives by identifying and targeting regions playing a central role in virus dispersal. In this study, we examined HCV transmission in Scotland by analyzing the genetic relatedness of strains from PWID alongside data inferring the year individuals became infected and residential information at a geographically finer-scale resolution than in previous studies. Clusters of Scotland-specific strains were identified with regional specificity, and mapping the spread of HCV allowed the identification of key areas central to HCV transmission in Scotland. This research provides a basis for identifying HCV transmission hot spots.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26311892      PMCID: PMC4645645          DOI: 10.1128/JVI.02106-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan.

Authors:  Irshad-Ur Rehman; Muhammad Idrees; Muhammad Ali; Liaqat Ali; Sadia Butt; Abrar Hussain; Haji Akbar; Samia Afzal
Journal:  Genet Vaccines Ther       Date:  2011-01-06

3.  High hepatitis C incidence in new injecting drug users: a policy failure?

Authors:  Lisa Maher; Jiong Li; Bin Jalaludin; Kerry G Chant; John M Kaldor
Journal:  Aust N Z J Public Health       Date:  2007-02       Impact factor: 2.939

4.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

5.  Multiple infections with different HCV genotypes: prevalence and clinical impact.

Authors:  Matthias Schröter; Heinz-Hubert Feucht; Bernhard Zöllner; Peter Schäfer; Rainer Laufs
Journal:  J Clin Virol       Date:  2003-07       Impact factor: 3.168

6.  Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.

Authors:  Maria de Lourdes Aguiar Oliveira; Francisco Inácio Bastos; Paulo Roberto Telles; Mariana de Andréa Hacker; Sabrina Alberti Nóbrega de Oliveira; Juliana Custódio Miguel; Clara Fumiko Tachibana Yoshida
Journal:  J Clin Virol       Date:  2009-02-04       Impact factor: 3.168

7.  Mixed genotype infections with hepatitis C virus, Pakistan.

Authors:  Sadia Butt; Muhammad Idrees; Irshad Ur Rehman; Haji Akbar; Muhammad Shahid; Samia Afzal; Saima Younas; Iram Amin
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

8.  Mixed genotype hepatitis C infections and implications for treatment.

Authors:  Anna L McNaughton; Emma C Thomson; Kate Templeton; Rory N Gunson; E Carol McWilliam Leitch
Journal:  Hepatology       Date:  2014-01-13       Impact factor: 17.425

9.  The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in different genomic regions.

Authors:  Manqiong Yuan; Teng Lu; Chunhua Li; Ling Lu
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

10.  Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

Authors:  Thijs J W van de Laar; Richard Molenkamp; Charlotte van den Berg; Janke Schinkel; Marcel G H M Beld; Maria Prins; Roel A Coutinho; Sylvia M Bruisten
Journal:  J Hepatol       Date:  2009-06-18       Impact factor: 25.083

View more
  8 in total

1.  The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study.

Authors:  Jeffrey B Joy; Rosemary M McCloskey; Thuy Nguyen; Richard H Liang; Yury Khudyakov; Andrea Olmstead; Mel Krajden; John W Ward; P Richard Harrigan; Julio S G Montaner; Art F Y Poon
Journal:  Lancet Infect Dis       Date:  2016-03-30       Impact factor: 25.071

2.  Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore.

Authors:  Jada Hackman; Oluwaseun Falade-Nwulia; Eshan U Patel; Shruti H Mehta; Gregory D Kirk; Jacquie Astemborski; Stuart C Ray; David L Thomas; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2019-10-24       Impact factor: 3.342

3.  Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.

Authors:  A L McNaughton; V B Sreenu; G Wilkie; R Gunson; K Templeton; E C M Leitch
Journal:  J Viral Hepat       Date:  2018-02-21       Impact factor: 3.728

4.  Epidemic history of hepatitis C virus genotypes and subtypes in Portugal.

Authors:  Claudia Palladino; Ifeanyi Jude Ezeonwumelu; Rute Marcelino; Verónica Briz; Inês Moranguinho; Fátima Serejo; José Fernando Velosa; Rui Tato Marinho; Pedro Borrego; Nuno Taveira
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

5.  HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of Infection.

Authors:  Dimitrios Paraskevis; Dora C Stylianou; Johana Hezka; Zachariah Stern; Martha Oikonomopoulou; Ioannis Mamais; Leondios G Kostrikis
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

6.  A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.

Authors:  Sofia R Bartlett; Tanya L Applegate; Brendan P Jacka; Marianne Martinello; Francois Mj Lamoury; Mark Danta; Daniel Bradshaw; David Shaw; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Gail V Matthews; Jason Grebely
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

7.  The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis.

Authors:  Ru Xu; Xia Rong; Elihu Aranday-Cortes; Sreenu Vattipally; Joseph Hughes; John McLauchlan; Yongshui Fu
Journal:  Viruses       Date:  2022-07-11       Impact factor: 5.818

8.  Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.

Authors:  Claudia Palladino; Ifeanyi Jude Ezeonwumelu; Irene Mate-Cano; Pedro Borrego; Paula Martínez-Román; Sonia Arca-Lafuente; Salvador Resino; Nuno Taveira; Verónica Briz
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.